Sevinc Can Sandikci

Dr. Sevinc Can Sandikci


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2018 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
SSSevinc Can Sandikci
Sevinc Can Sandikci
SCSeda Colak
Seda Colak
AOAhmet Omma
Ahmet Omma
MEMehmet E. Enecik
Mehmet E. Enecik

12 November 2018 in Zeitschrift für Rheumatologie
Verified
Journal Article
Closed access
PDF file
SSSevinc Can Sandikci
Sevinc Can Sandikci
SCS. Colak
S. Colak
RBRabia Aydoğan Baykara
Rabia Aydoğan Baykara
AÖA. Öktem
A. Öktem
ECE. Cüre
E. Cüre
AKA. Kucuk
A. Kucuk

1 January 2017 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
AOAhmet Omma
Ahmet Omma
SSSevinc Can Sandikci
Sevinc Can Sandikci
OKOrhan Kucuksahin
Orhan Kucuksahin
MAMurat Alisik
Murat Alisik
ÖEÖzcan EREL
Özcan EREL
Omma A, et al. J Korean Med Sci. 2017 Oct;32(10):1588-1594. https://doi.org/10.3346/jkms.2017.32.10.1588

14 August 2019 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
AOAhmet Omma
Ahmet Omma
SCSeda Colak
Seda Colak
SSSevinc Can Sandikci
Sevinc Can Sandikci
ÇYçiğdem yücel
çiğdem yücel
AEAbdulsamet Erden
Abdulsamet Erden
TOTaner Ozgurtas
Taner Ozgurtas

17 December 2021 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
ESErdim Sertoglu
Erdim Sertoglu
ÇYçiğdem yücel
çiğdem yücel
AOAhmet Omma
Ahmet Omma
YHYildiz Hayran
Yildiz Hayran
SCSeda Colak
Seda Colak
TOTaner Ozgurtas
Taner Ozgurtas
Behçet's disease (BD) is a chronic inflammatory vasculitis affecting multiple organs. Uveitis is frequently seen in patients with BD, especially in Turkish population. To investigate vascular endothelial growth factor (VEGF) gene polymorphisms along with the levels of VEGF and VEGF receptors in patients with Behçet's uveitis (BU). Fifty-five BD-associated uveitis patients and 30 ageand sex-matched controls were included in this case-control study. The genotypes of the single nucleotide poymorphisms (SNPs): rs2010963 (+405G), rs3025039 (+936T) and rs699947 (-2598A) of the VEGF-A gene were determined using real-time polymerase chain reaction (RT-PCR) and serum levels of VEGF and VEGF receptors were measured using enzyme-linked immunosorbent assay (ELISA). No associations of the VEGF gene polymorphisms were observed in BD uveitis patients, but arthritis was present in 53.3% of patients not possessing CT genotype in C3025039→T polymorphism (p = 0.024). Although there were no statistically significant differences in serum VEGF-A, VEGF-C and soluble vascular endothelial growth factor receptor-3 (sVEGFR-3) levels (p < 0.05), serum vascular endothelial growth factor receptor-1 (VEGFR-1) and sVEGFR-3 levels were significantly higher in the BD group (p < 0.001 and p = 0.001, respectively). In addition, VEGF-C/soluble vascular endothelial growth factor receptor-2 (sVEGFR-2) ratio was significantly higher (p < 0.001), while VEGF-A/VEGFR-1 and VEGF-C/sVEGFR-3 ratios were significantly lower (p < 0.001 and p = 0.033, respectively) in BD patients compared to controls. Also, VEGF-C/sVEGFR-3 (p = 0.024, r = 0.37) and VEGF-C/sVEGFR-2 (p = 0.020, r = 0.38) ratios were positively correlated with disease duration. The significant changes in sVEGFR-3 levels and VEGF-C/sVEGFR-3 ratio has shown that lymphangiogenesis processes might take place in the pathogenesis of BD uveitis, and these parameters can be important indicators of evaluation of BD patients with uveitis together with disease duration.